1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends

The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects

  • December 2015
  • 67 pages
  • GBI Research
Report ID: 3572546

Summary

Table of Contents

The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects

Summary

GBI Research’s latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current market drivers and restraints, mergers and acquisitions (M&A) activity and recent regulatory developments in key national markets. Furthermore, this report analyses leading therapeutic segments in the OTC drugs market, key brands, manufacturers and the potential for new product categories to be created as more prescription-only drugs from diverse therapy areas continue to be considered for OTC approval. Detailed case studies of recent Rx-to-OTC switches provide the rationale for these switches including description of their economic and financial impact.

The OTC drugs market remains highly competitive and fragmented albeit leading companies continue to consolidate their market position through high-profile and strategic acquisitions. GBI Research expects M&A to remain very active in the coming years fueled by strategic long-term commercial priorities, as companies look to increase revenues through expanded OTC portfolios. A positive regulatory outlook in key markets, due to new initiatives and frameworks looking to facilitate OTC approvals, will also prompt companies to seek access to new markets. The global OTC drugs market will continue to be largely driven by demographics, economic trends and changes in cultural attitudes towards self-medication. An increasing interest in self-medication in both developed and developing countries has been identified as a major contributor to market growth in recent years.

GBI Research conducted extensive primary and secondary research efforts in order to provide a comprehensive view of the regulatory, commercial and competitive landscape in the OTC drugs market. Our new report will let you assess the most promising commercial areas in the market and help you identify key opportunities and challenges.

Scope

- How do consumers, payers and manufacturers benefit from Rx-to-OTC switches?
- What are the key factors promoting the usage of OTC drugs?
Current trends in the OTC drugs market
- What attitudes do consumers have towards OTC drugs?
- How are new distribution channels, technologies and education reshaping the OTC drugs market?
- What will be the impact of new regulatory initiatives and frameworks on future Rx-to-OTC switches in key markets?
- What have been the preferred types of M&A deals in the OTC drugs market in recent years?
- Which OTC drug manufacturers have been the most active in terms of mergers and acquisitions in recent years?
- What are the current regulations and frameworks established in key developed and developing markets for OTC approval and Rx-to-OTC switches?
- Which OTC drug product categories and drug classes have experienced the most switches in recent years?
- Which new products categories are expected to enter the OTC drugs market in the coming years?
- What has been the economic and financial impact of recent Rx-to-OTC switches?
- Who are the leading OTC drug manufacturers and what are their OTC segments of interest?
Market analysis of the leading OTC product categories including cough, cold, and allergy, analgesics, gastrointestinal and dermatological drugs.

Reasons to buy

This report will allow you to -
- Gain insights into the OTC drugs market and future prospects for Rx-to-OTC switches: This report comprehensively describes and assesses the commercial, regulatory and competitive landscape in this highly dynamic and lucrative industry.
- Understand differing regulatory frameworks for OTC drugs and Rx-to-OTC switches in key markets: This report provides insights about established regulatory processes, approval frameworks and recent developments in the US, Europe, Japan, India and China for OTC drugs.
- Assess M&A activity in the OTC drugs market: This report provides detailed analysis on M&A deals in recent years including trends on preferred types of deals, factors contributing to the surge in transactions and identifies the most active companies in the OTC drugs market.
- Assess the market for the leading OTC product categories: Our new study provides market analyses of the key product categories including revenues in key national markets, key brands, key manufacturers, market drivers, restraints, recent switches and potential candidates for future Rx-to-OTC switch.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Migraine Disease Coverage Forecast and Market Analysis

  • $ 22000
  • Industry report
  • July 2017
  • by Datamonitor Healthcare

Introduction Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range ...

Vitamin and Provitamin Markets in the World to 2021 - Market Size, Development, and Forecasts

  • $ 23395
  • Industry report
  • July 2017
  • by Global Research & Data Services

The industry report package Vitamin and Provitamin Markets in the World to 2021 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future ...

Vitamin and Provitamin Markets in Europe to 2021 - Market Size, Development, and Forecasts

  • $ 12090
  • Industry report
  • July 2017
  • by Global Research & Data Services

The industry report package Vitamin and Provitamin Markets in Europe to 2021 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future ...


Download Unlimited Documents from Trusted Public Sources

Oral Care Industry in China - Forecast

  • August 2017
    4 pages
  • Oral Care  

    Clinic  

  • China  

View report >

Genitourinary System Disease Statistics and Therapy Market in the US - Forecast

  • August 2017
    2 pages
  • Genitourinary S...  

    Therapy  

    Anti-Infective  

  • United States  

View report >

Rice Markets in Australia and New Zealand

  • August 2017
    25 pages
  • Rice  

    Vitamin  

    Nutrition  

  • Australia  

    New Zealand  

    Oceania  

View report >

Milk Industry

22 days ago

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.